Clinical trials: Primary Axillary Hyperhidrosis
Primary Axillary Hyperhidrosis
Ulthera® System for Treating Axillary Hyperhidrosis
Up to 20 enrolled subjects will be treated. Subjects will receive two Ulthera® treatments on the axillas provided 30 days apart. Follow-up visits will occur at 7, 30, 90 and 180 days following the last treatment.
- Trial name
- NCT02286765
- Testing
- Ulthera System treatment
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Ulthera, Inc
Primary Axillary Hyperhidrosis
Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis
Because of the limiting data about an efficacy and safety of fractional radiofrequency for the treatment of hyperhidrosis, this study aim to compare clinical efficacy by Hyperhidrosis Disease Severity Score (HDSS) between…
- Trial name
- NCT03054480
- Testing
- Fractional Micro-Needle Radiofrequency, Botulinum toxin type A
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Mae Fah Luang University Hospital
Hyperhidrosis Primary Focal Axilla
Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency
The InMode radio frequency Pro System with the Morpheus8 Applicator is a computerized system generating radio frequency energy, based on the underlying technology of Fractional RF.
- Trial name
- NCT05860972
- Testing
- Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis.
- Where
- 4 sites in United States, Israel
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- InMode MD Ltd.